Replies to post #439812 on Anavex Life Sciences Corp (AVXL)

[Joseph_K]

"But how complicated would be a new clinical trial testing for resolution of insomnia and/or agitation with blarcamesine?"

I remember something about the FDA moving toward permitting individual trials to address, and be used for NDAs for, multiple indications. Anyone else remember this? If I'm remembering that correctly, it seems an insomnia/anxiety trial could maybe be folded into a trial for something else.